Funded research by Professor Norman Maitland of University of York into the study of ELF3 gene and its role in prostate cancer aggressiveness.
Funded research by Dr Claire Edwards of University of Oxford into understanding how prostate cancer spreads to the bone and find new therapies.
Funded research by Dr Andrew Chantry and Jessica Watt of the University of East Anglia into new ways to prevent the growth of prostate cancer.
Funded research by Dr Jason Webber of Cardiff University which looks at identifying novel exosomal molecules essential for tumour growth, which are present in blood, as indicators of aggressive disease.
Funded research by Dr Ananya Choudhury of the University of Manchester which looks to identify patients with low oxygen (hypoxic) prostate cancers. This will allow doctors to select patients who are most likely to benefit from appropriate radiotherapy.
Some men report changes in their thinking abilities after treatment with hormone therapy for their advanced prostate cancer. Now, we’re funding Professor Beth Grunfeld to conduct a clinical study to learn more about who these changes might affect, and why.
Funded research by Dr Hayley Whitaker of University College London which aims to define which patients will benefit from diagnostic multiparametric (mp)MRI before biopsy and to improve the performance of the mpMRI itself.
Funded research by Dr Dow-Mu Koh of Royal Marsden Hospital which looks to test whether a technique called whole body diffusion weighted imaging is a reliable method of how well patients with advanced prostate cancer, who have been treated with olaparib, are responding to treatment.
Funded research by Professor Hing Leung of the University of Glasgow which looks at whether adding statins to hormone treatment will improve treatment response in hormone resistant disease, and whether any new tests can track how well the cancer is responding to treatment.
Improved technology for imaging prostate cancer, like mpMRI, has helped transform diagnosis of the disease. Professor Nabi wants to add to the evidence that prostate imaging technologies should be made widely available to continue to improve diagnosis of the disease.
Funded research by Dr Justin Sturge of Hull University to assess prostate cancer aggressiveness and give an early indication of whether treatment is necessary.
Funded research by Prof. Gwyn Williams of Keele University into GAS5 and prostate cancer drug resistance.
Funded research by Dr Luke Gaughan of Newcastle University which looks to understand how different forms of the androgen receptor are regulated in advanced prostate cancer.
Funded research by Dr Jonathan Coulter of Queens University Belfast investigating the use of a reactive oxygen species to damage the cancer cell membrane.
Turning microRNAs, a new type of genetic material, into a way to treat advanced prostate cancer
Funded research by Dr Joanne Edwards of Glasgow University into new ways to treat advanced prostate cancer after hormone therapy stops working.
Funded research by Dr Anita Grigoriadis of King's College London looking at finding DNA markers to identify men whose prostate cancer does not need treatment and can be managed by surveillance alone.
Funded research by Prof. Rosalind Eeles and Dr Zsofia Kote-Jarai of the Institute of Cancer Research into genetic changes in the DNA repair genes and their relationship with aggressive disease.
Funded research by Professor Charlotte Bevan of Imperial College London looking at improving targeted therapy for men with prostate cancer.
Funded research by Dr Hayley Whitaker of University College London looking at combining markers with imaging to improve the diagnosis and treatment of prostate cancer in a way that can easily be adopted by the NHS.
Funded Research by Dr Matthew David Lloyd of University of Bath to discover new drugs to specifically block the function of a protein called AMACR, which is involved in prostate cancer growth
Research Funded by Dr Nicholas Leslie of Heriot Watt University investigating how loss of a gene called PTEN leads to aggressive prostate cancers.
Funded Research by Professor Myra Olga McClure of Imperial College London which looked at whether a virus infection explains why some people of African and African-Caribbean origin are at greater risk of prostate cancer.
Funded research by Dr Alastair Lamb of the University of Cambridge which will involve transferring human prostate cancer to mice to better understand how individual prostate cancers behave and which treatments they respond to.
Funded research by Dr Rich Williams of Queen's University Belfast into how inhibiting Legumain may improve prognosis.